CEFTAZIDIME VS TOBRAMYCIN FOR SERIOUS INFECTIONS IN UROLOGICAL PATIENTS

被引：3
|
作者：
TAMMELA, T
KONTTURI, M
USENIUS, R
UUSIPENTTILA, S
VIITANEN, J
JAUHIAINEN, K
机构：
[1] JYVASKYLA CENT HOSP,UROL UNIT,OULU,FINLAND
[2] JOENSUU CENT HOSP,UROL UNIT,OULU,FINLAND
来源：
JOURNAL OF HOSPITAL INFECTION | 1990年 / 15卷
关键词：
D O I：
10.1016/0195-6701(90)90083-Z
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
A prospective, randomized study was undertaken to compare the efficacy and safety of tobramycin and ceftazidime in the treatment of serious infections in 77 urological patients. Of the 39 tobramycin-treated and 38 ceftazidime-treated patients, 74% and 82%, respectively, were cured clinically. Microbiological cure rates were 72% and 79%, respectively. Three patients treated with tobramycin and two treated with ceftazidime developed a significant superinfection. Both drugs were tolerated well. Because of potential ototoxicity and nephrotoxicity the use of aminoglycosides is less advantageous than ceftazidime for seriously infected urological patients. © 1990.
引用
收藏
页码：69 / 76
页数：8
相关论文
共 50 条
  • [1] CEFTAZIDIME MONOTHERAPY VS CEFTRIAXONE TOBRAMYCIN FOR SERIOUS HOSPITAL-ACQUIRED GRAM-NEGATIVE INFECTIONS
    RUBINSTEIN, E
    LODE, H
    GRASSI, C
    CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) : 1217 - 1228
  • [2] A RANDOMIZED STUDY OF CEFTAZIDIME COMPARED TO CEFTAZIDIME AND TOBRAMYCIN FOR THE TREATMENT OF INFECTIONS IN CANCER-PATIENTS
    FAINSTEIN, V
    BODEY, GP
    ELTING, L
    BOLIVAR, R
    KEATING, MJ
    MCCREDIE, KB
    VALDIVIESO, M
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 : 101 - 110
  • [3] CEFTAZIDIME THERAPY FOR SERIOUS INFECTIONS
    BINT, AJ
    CONSTABLE, J
    PATTON, KR
    CONSTABLE, FL
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 : 115 - 121
  • [4] CEFTAZIDIME MONOTHERAPY VS CEFTRIAXONE TOBRAMYCIN FOR SERIOUS HOSPITAL-ACQUIRED GRAM-NEGATIVE INFECTIONS (VOL 20, PG 1217, 1995)
    RUBINSTEIN, E
    CLINICAL INFECTIOUS DISEASES, 1995, 20 (06) : 1582 - 1582
  • [5] PROSPECTIVE, CONTROLLED, RANDOMIZED COMPARISON OF INTRAVENOUS CIPROFLOXACIN VS INTRAVENOUS CEFTAZIDIME FOR THE TREATMENT OF PATIENTS WITH SERIOUS INFECTIONS
    QUINTEROPEREZ, NP
    ANDRADEVILLANUEVA, JF
    LEONGARNICA, G
    BERTINMONTANO, M
    ORTIZCOVARRUBIAS, A
    DELEON, AP
    RODRIGUEZCHAGOLLAN, JJ
    RODRIGUEZNORIEGA, E
    REVIEWS OF INFECTIOUS DISEASES, 1989, 11 : S1167 - S1168
  • [6] CIPROFLOXACIN VERSUS CEFTAZIDIME IN SERIOUS INFECTIONS
    REINHARDT, JF
    BACON, AE
    WINSLOW, DL
    HOLLOWAY, WJ
    AMERICAN JOURNAL OF MEDICINE, 1989, 87 (5A): : S181 - S182
  • [7] CEFTAZIDIME IN SERIOUS BACTERIAL-INFECTIONS
    MORFELDTMANSON, L
    WEILAND, O
    LUNDBERGH, P
    JARSTRAND, C
    CLINICAL TRIALS JOURNAL, 1985, 22 (01) : 55 - 62
  • [8] The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis
    Blumer, JL
    Saiman, L
    Konstan, MW
    Melnick, D
    CHEST, 2005, 128 (04) : 2336 - 2346
  • [9] CEFTAZIDIME THERAPY OF SERIOUS BACTERIAL-INFECTIONS
    ERON, LJ
    GOLDENBERG, RI
    PARK, CH
    PORETZ, DM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (02) : 236 - 241
  • [10] CEFTAZIDIME IN SERIOUS HOSPITAL-ACQUIRED INFECTIONS
    HOOGKAMPKORSTANJE, JAA
    VANERPECUM, KJ
    VANKAMP, H
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 (06) : 743 - 749
12345